Aska Pharmaceutical Signs License With Sosei On Emergency Contraception Drug
This article was originally published in PharmAsia News
Executive Summary
Aska Pharmaceutical signed a license agreement with Sosei Oct. 21 and obtained exclusive rights to market SOH-075, an emergency contraception pill Sosei in-licensed from French Laboratoire HRA Pharma. SOH-075 completed Phase III trials in Japan and an approval is expected by the early half of 2009. According to the agreement, Sosei will receive a ¥300 million upfront payment, as well as potential milestone and royalty payments. Sosei will apply for the new drug approval and Aska will market the drug and conduct post-market surveillance. (Click here for more - Japanese language